Intensive BP Lowering Benefits Deep but Not Lobar Hemorrhage

A pooled individual patient-level analysis of five randomized trials (INTERACT1-4 and ATACH-II), totaling 11,288 patients with acute intracerebral hemorrhage, examined whether the benefit of early intensive blood pressure lowering varies by hematoma location. The analysis reported that treatment effect on death or disability at 90 days or 6 months differed significantly by location, with a clear benefit observed only in deep hemisphere ICH (adjusted odds ratio 0.81) and no clear benefit shown for lobar or infratentorial hemorrhage.

Most relevant for: Patients presenting with acute intracerebral hemorrhage, particularly where hematoma location (deep, lobar, or infratentorial) is being considered in blood pressure management decisions.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.